Leucine Aminopeptidase as a Target for Inhibitor Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|1|2|133-144

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.1, Iss.2, 2001-07, pp. : 133-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aminopeptidase N (APN/CD13) as a Target for Anti-Cancer Agent Design

By  

Current Medicinal Chemistry, Vol. 15, Iss. 27, 2008-11 ,pp. : 2850-2865

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advance in Aminopeptidase N (APN/CD13) Inhibitor Research

By  

Current Medicinal Chemistry, Vol. 18, Iss. 32, 2011-11 ,pp. : 5011-5021

Bentham Science Publishers

Access to resources Recommend Favorite

The Synthesis and Activity Evaluation of a Bestatin Derivative (LYP) as an Aminopeptidase N Inhibitor

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 6, 2009-09 ,pp. : 420-423

Bentham Science Publishers

Access to resources Recommend Favorite

Plasmodium falciparum M1-Aminopeptidase: A Promising Target for the Development of Antimalarials

By  

Current Drug Targets, Vol. 15, Iss. 12, 2014-11 ,pp. : 1144-1165

Bentham Science Publishers

Access to resources Recommend Favorite

Leucine-zipper and Sterile-α Motif Kinase (ZAK): A Potential Target for Drug Discovery

By  

Current Medicinal Chemistry, Vol. 23, Iss. 33, 2016-10 ,pp. : 3801-3812

Bentham Science Publishers

Access to resources Recommend Favorite